Please provide your email address to receive an email when new articles are posted on . Percent predicted FEV 1 did not improve after systemic corticosteroid treatment. This treatment was also not ...

It is written: both systemic and topical corticosteroids can exacerbate or precipitate acne or even induce an acneform eruption. Corticosteroids are considered to be acnegenic comedogenic drugs, and ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. In a new study, approved asthma biologics and systemic ...

Intravenous corticosteroids didn't hurt people with acute heart failure (HF), and had the potential to pay off in better outcomes for some in a hypothesis-generating study based on Spain's ...

A review in Current Allergy and Asthma Reports highlights how acute exacerbations of chronic rhinosinusitis (AECRS) remain poorly defined, inconsistently diagnosed, and often overtreated with ...

The more often a patient used systemic corticosteroids, the higher their risk of moderate or severe COVID-19 and all-cause mortality, the study found. Patients who take biologics or systemic ...

Patients with sickle cell disease (SCD) have an increased risk of vaso-occlusive episodes (VOE) after exposure to corticosteroids, according to a French population-based study. Those taking systemic ...

Risks in an era of COVID-19 The current COVID-19 pandemic serves to highlight the risk of using systemic corticosteroids and, to a lesser extent, other immunosuppressive therapy, in populations with ...

A real-world study of more than 20,000 births shows an association between maternal gestational systemic glucocorticoid exposure and increased risk for childhood CKD. Exposure to systemic ...

Dupilumab, a fully human monoclonal antibody, inhibits the signaling of the interleukin 4 (IL-4) and IL-13 pathways.